BOLT BIOTHERAPEUTICS, INC. CONSULTING AGREEMENTConsulting Agreement • May 14th, 2024 • Bolt Biotherapeutics, Inc. • Pharmaceutical preparations
This Consulting Agreement (“Agreement”) is entered into as of May 13, 2024 and will be effective as of July 15, 2024 (the “Effective Date”) between Bolt Biotherapeutics, Inc. (“Company”) and Randall C. Schatzman, Ph.D. (“Consultant”). Company desires to retain Consultant to perform certain consulting activities as described below, and Consultant desires to serve as a consultant to Company and perform such activities under the terms of this Agreement.
